Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Foster

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Transplantation Proceedings|October 1, 1988
Chronic renal allograft rejection and cyclosporineP A Rowe, M C Foster, R E Richardson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 1, 1989
The increasing importance of chronic rejection as a cause of renal allograft failureM J Dennis, M C Foster, J J Ryan, et al.
Annals of the Royal College of Surgeons of England|January 1, 1990
Characteristics of cadaveric renal allograft recipients developing chronic rejectionM C Foster, P A Rowe, M J Dennis, et al.
The British Journal of Surgery|August 1, 1988
Use of older patients as cadaveric kidney donorsM C Foster, P W Wenham, P A Rowe, et al.
Annals of the Royal College of Surgeons of England|January 1, 1989
The late results of renal transplantation and the importance of chronic rejection as a cause of graft lossM C Foster, P W Wenham, P A Rowe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2015
Estimated GFR for Living Kidney Donor EvaluationN Huang, M C Foster, K L Lentine, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 4, 2017
Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT TrialM C Foster, D E Weiner, A G Bostom, et al.
ESMO Open|August 27, 2021
Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD studyR de Wit, C Wülfing, D Castellano, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Transplantation Proceedings|October 1, 1988
Chronic renal allograft rejection and cyclosporineP A Rowe, M C Foster, R E Richardson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 1, 1989
The increasing importance of chronic rejection as a cause of renal allograft failureM J Dennis, M C Foster, J J Ryan, et al.
Annals of the Royal College of Surgeons of England|January 1, 1990
Characteristics of cadaveric renal allograft recipients developing chronic rejectionM C Foster, P A Rowe, M J Dennis, et al.
The British Journal of Surgery|August 1, 1988
Use of older patients as cadaveric kidney donorsM C Foster, P W Wenham, P A Rowe, et al.
Annals of the Royal College of Surgeons of England|January 1, 1989
The late results of renal transplantation and the importance of chronic rejection as a cause of graft lossM C Foster, P W Wenham, P A Rowe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2015
Estimated GFR for Living Kidney Donor EvaluationN Huang, M C Foster, K L Lentine, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 4, 2017
Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT TrialM C Foster, D E Weiner, A G Bostom, et al.
ESMO Open|August 27, 2021
Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD studyR de Wit, C Wülfing, D Castellano, et al.
Pageof 4